The strategic combination brings leading-edge product Felycin®-CA1 (Sirolimus Delayed-Release Tablets) and innovative pipeline together with PRN® Pharmacal leading expertise in commercializing new therapies for chronic pet health conditions Shawnee, Kansas, May 5,...
Recent Comments